The administration of low molecular weight heparin in severe case of covid-19, a case report

Ngakan Ketut Wira Suastika¹, Ketut Suega², Putu Utami Dewi¹
¹Udayana University Hospital, Bali, Indonesia
²Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Udayana University, Bali Indonesia

Coagulopathy and disseminated intravascular coagulation (DIC) is one of the complications of the corona virus disease 2019 (Covid-19) that can lead to death. Several studies have shown that anticoagulants provide good clinical outcomes in Covid-19 patients, especially in severe cases. This case emphasizes the administration of low molecular weight heparin (LMWH) to prevent venous thromboembolism (VTE) in severe case of Covid-19.

Keywords: Covid-19, coagulopathy, thromboembolism, anticoagulant

Ngakan Ketut Wira Suastika, Ketut Suega, Putu Utami Dewi. The administration of low molecular weight heparin in severe case of covid-19, a case report. Eastern J Med. 2020; 25(3): 461-464

Sorumlu Yazar: Ngakan Ketut Wira Suastika, Indonesia

ARAÇLAR

Tam Metin PDF

Yazdır

Alıntıyı İndir

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

E-Postala

Paylaş

Yazara e-posta gönder

Benzer makaleler

PubMed

Google Scholar